Yield10 Bioscience, Inc. Stock
Stocks
YTENQ
US98585K8541
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -99.33% |
|
-.--% | +9,900.00% |
| 25-10-31 | Yield10 Bioscience, Inc. Went Out of Business | CI |
| 25-10-14 | First Amended Joint Liquidation Plan Approved for Yield10 Bioscience, Inc. | CI |
| Market Cap | 229K 198K 185K 169K 319K 21.85M 324K 2.17M 853K 10.93M 860K 842K 36.41M | P/E 2022 |
-0.6x | P/E 2023 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 2.34M 2.02M 1.89M 1.73M 3.26M 223M 3.31M 22.2M 8.71M 112M 8.78M 8.59M 372M | EV / Sales 2022 |
14.6x | EV / Sales 2023 | 83x |
| Free-Float |
86% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +9,900.00% | ||
| Current month | +9,900.00% | ||
| 1 month | +9,900.00% | ||
| 3 months | +9,900.00% | ||
| Current year | +9,900.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 17.26 |
| 5 years | 0 | | 210.24 |
| 10 years | 0 | | 8,927.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oliver Peoples
CEO | Chief Executive Officer | 68 | 2016-10-16 |
Charles Haaser
DFI | Director of Finance/CFO | 70 | 2014-11-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Oliver Peoples
BRD | Director/Board Member | 68 | 2009-07-06 |
| Chairman | 69 | 2011-11-07 | |
Richard Hamilton
BRD | Director/Board Member | 63 | 2017-03-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/15/24 | Tax | Chief Technology Officer | 877 | 0.1365% | ||
| 8/15/24 | Tax | Chief Financial Officer | 731 | 0.1138% | ||
| 8/15/24 | Tax | Investor Relations Manager | 731 | 0.1138% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.33% | -.--% | -.--% | -100.00% | 73 | |
| -0.60% | +3.46% | +6.43% | +16.36% | 50.03B | |
| +0.89% | +13.44% | +491.34% | +594.30% | 44.36B | |
| +3.08% | +14.42% | +24.57% | +81.39% | 40.82B | |
| +1.38% | +3.70% | +34.54% | +9.11% | 39.83B | |
| +0.85% | +10.32% | +21.22% | +47.64% | 32.51B | |
| +0.08% | +5.00% | - | - | 16.85B | |
| +1.99% | +5.08% | +38.70% | +125.08% | 16.81B | |
| -0.09% | +3.40% | +5.39% | +18.79% | 14.05B | |
| +3.56% | +19.98% | +86.23% | +27.29% | 13.22B | |
| Average | +991.35% | +996.59% | +78.71% | +91.11% | 26.85B | |
| Weighted average by Cap. | +1.49% | +7.09% | +107.51% | +139.66% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 450K 390K 364K 333K 627K 42.92M 637K 4.27M 1.68M 21.47M 1.69M 1.65M 71.51M | 60K 51.94K 48.55K 44.37K 83.62K 5.72M 84.92K 569K 223K 2.86M 225K 220K 9.53M |
| Net income | -13.57M -11.74M -10.98M -10.03M -18.91M -1.29B -19.2M -129M -50.51M -647M -50.94M -49.83M -2.16B | -14.46M -12.51M -11.7M -10.69M -20.14M -1.38B -20.46M -137M -53.82M -690M -54.28M -53.09M -2.3B |
| Net Debt | -1.7M -1.47M -1.37M -1.25M -2.36M -162M -2.4M -16.1M -6.32M -80.97M -6.37M -6.23M -270M | 2.11M 1.83M 1.71M 1.56M 2.94M 201M 2.99M 20.02M 7.86M 101M 7.92M 7.75M 335M |
Employees
29
| Date | Price | Change | Volume |
|---|
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YTENQ Stock
Select your edition
All financial news and data tailored to specific country editions
